VV
Vanessa Villard
Chief Executive Officer at Amylgen
View Vanessa's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Chief Executive Officer
2009 - Present · 16 years
Ingã Nieur D'Ã Tude - Doctorante
2006 - 2009 · 3 years
Company Details
2-10 Employees
Amylgen is a CRO proposing innovative in vivo models of ageing, psychiatric and neurodegenerative pathologies for the development of new medicines or nutraceuticals. Amylgen is at your service to provide quick POC for your product as a food supplement for brain health and helps you to substantiate the efficacy of your product by preclinical studies in rodent models Amylgen brings you preclinical scientific data for your product on Brain aging preservation Memory enhancement Antidepressant /anti anxiety effect Protection against Alzheimer’s disease   Amylgen has access to regulatory and clinical partners to aid in the preparation of health claims for EFSA or FDA and the commercialization of your product
Year Founded
2009
Social Media
LinkedinFacebookTwitter
Industry
Research Services, Biotechnology research and development, Research and testing, IT, Internet, R&D, Research, general
HQ Location
2196 Boulevard de la Lironde Montferrier sur Lez, 34 980, FR
Keywords
in vivo pharmacologyBehavioral pharmacologyeurodegenerative diseasesCentral nervous system
Discover More About Cleveland Clinic

Find verified contacts of Vanessa Villard in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.